You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis

Article info

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Scleroderma, myositis and related syndromes – clinical aspects and treatment
FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis

Authors

Citation

Endo H, Yamamoto T, Kusunoki Y, et al
FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis
Annals of the Rheumatic Diseases 2013;71:401.

Publication history

  • First published January 23, 2014.
Online issue publication 
March 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions